Drawing for KLINIPRESS

USPTO serial 79200976

KLINIPRESS

Reviewed by CopyMark Law Group

Reg. 5398498Status 709
Filing date
Status date
Registration date
Feb 13, 2018
Examiner
LAVACHE, LINDA M
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with KLINIPRESS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jamie E. Sternberg

Jamie E. Sternberg Cantor Colburn LLP20 Church Street22nd FloorHartford, CT 06103

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of wounds and sores; sanitary preparations for medical use; sanitary preparations for medical use, namely, gauzes and wound dressings, namely, wound covering foils; disinfectants and antiseptics; wadding, swabs, wound dressings and bandages for skin wounds made of cotton wool for medical purposes; medical plasters, medicated compresses, bandages, absorbent cotton, and adhesive bands for medical purposes, all for dressing; first aid kits, filled; surgical gluesSECTION 71 - CANCELLED—
010Surgical apparatus and instruments; gloves for medical and surgical use; medical clothing, namely, medical gowns, protective clothing for medical purposes, namely, surgical gowns, surgical scrub suits, surgical gloves, surgical caps, surgical masks; protective caps and protective bonnets, namely, medical wearing caps for the hair; disposable shoe covers in the nature of surgical shoe covers; suture materials; elastic bandages; sports tapes, namely, orthopedic support bandages; syringes for injections; hypodermic needles; lancets; containers especially adapted for the purpose of the disposal of sharps medical syringes; slings; orthopaedic hosiery; medical compression stockingsSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 6, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Sep 5, 2025INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Aug 15, 2025INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Aug 15, 2025INPCINVALIDATION PROCESSED—
Apr 30, 2025INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Aug 30, 2024C71TCANCELLED SECTION 71—
Feb 13, 2023REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jun 29, 2018FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
May 22, 2018FICSFINAL DISPOSITION NOTICE SENT TO IB—
May 22, 2018FIMPFINAL DISPOSITION PROCESSED—
May 13, 2018FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Feb 13, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 8, 2017GPNXNOTIFICATION PROCESSED BY IB—
Nov 28, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 28, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 22, 2017OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Nov 22, 2017OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Nov 8, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 25, 2017PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 23, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 20, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 19, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 19, 2017ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Sep 15, 2017GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Sep 15, 2017GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 15, 2017CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 29, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 29, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 23, 2017ALIEASSIGNED TO LIE—
Aug 2, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 4, 2017RFNPREFUSAL PROCESSED BY IB—
Feb 15, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 15, 2017RFRRREFUSAL PROCESSED BY MPU—
Feb 14, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 14, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 13, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 8, 2017DOCKASSIGNED TO EXAMINER—
Feb 8, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 2, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance